Analysis Article • Jun 05
Have your own idea? Try our Stock Screener
Polish (WIG) Life Sciences Industry Analysis
UpdatedAug 05, 2026
DataAggregated Company Financials
Companies4
- 7D4.4%
- 3M-23.3%
- 1Y-33.0%
- YTD-37.0%
Over the last 7 days, the Life Sciences industry has risen 4.4%, driven by gains from Selvita of 8.7%. In the same time, Medicofarma Biotech was down 6.0%. In the past year, the industry is down 33%. Earnings are forecast to grow by 34% annually.
Industry Valuation and Performance
Has the Polish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 05 Aug 2026 | zł995.6m | zł447.8m | -zł104,204,195.00 | n/a | -9.6x | 2.2x |
| Fri, 03 Jul 2026 | zł1.1b | zł448.4m | -zł104,204,195.00 | n/a | -10.2x | 2.4x |
| Sun, 31 May 2026 | zł1.1b | zł448.4m | -zł104,204,195.00 | n/a | -10.2x | 2.4x |
| Tue, 28 Apr 2026 | zł1.2b | zł459.0m | -zł102,646,524.00 | 790.2x | -11.9x | 2.7x |
| Thu, 26 Mar 2026 | zł1.2b | zł461.9m | -zł107,178,157.00 | n/a | -11x | 2.5x |
| Sat, 21 Feb 2026 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -11.3x | 3x |
| Mon, 19 Jan 2026 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -12.2x | 3.3x |
| Wed, 17 Dec 2025 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -11.2x | 3x |
| Fri, 14 Nov 2025 | zł1.4b | zł507.6m | -zł114,663,001.00 | 1642.1x | -12.3x | 2.8x |
| Sun, 12 Oct 2025 | zł1.4b | zł507.6m | -zł114,663,001.00 | 1425x | -11.9x | 2.7x |
| Tue, 09 Sep 2025 | zł1.4b | zł460.9m | -zł129,094,851.00 | 37.8x | -11.1x | 3.1x |
| Thu, 07 Aug 2025 | zł1.5b | zł461.1m | -zł128,888,382.00 | 38.8x | -11.7x | 3.3x |
| Sat, 05 Jul 2025 | zł1.4b | zł461.1m | -zł128,888,382.00 | 33.1x | -11.2x | 3.1x |
| Mon, 02 Jun 2025 | zł1.4b | zł457.8m | -zł130,948,382.00 | n/a | -10.4x | 3x |
| Wed, 30 Apr 2025 | zł1.6b | zł452.3m | -zł123,092,243.00 | 49.3x | -13x | 3.5x |
| Fri, 28 Mar 2025 | zł1.6b | zł440.9m | -zł62,900,243.00 | 32x | -24.7x | 3.5x |
| Sun, 23 Feb 2025 | zł1.7b | zł427.2m | -zł63,400,243.00 | 16.9x | -27.4x | 4.1x |
| Tue, 21 Jan 2025 | zł1.7b | zł427.0m | -zł65,964,174.00 | 15.5x | -26.4x | 4.1x |
| Thu, 19 Dec 2024 | zł2.0b | zł427.0m | -zł65,964,174.00 | 17.3x | -29.8x | 4.6x |
| Sat, 16 Nov 2024 | zł2.2b | zł421.9m | -zł72,811,689.00 | 19.9x | -30.3x | 5.2x |
| Mon, 14 Oct 2024 | zł2.5b | zł413.2m | -zł64,500,689.00 | 23.5x | -38.4x | 6x |
| Wed, 11 Sep 2024 | zł2.4b | zł413.4m | -zł37,576,869.00 | 17.1x | -64.1x | 5.8x |
| Fri, 09 Aug 2024 | zł2.4b | zł413.5m | -zł32,092,283.00 | 17.9x | -75.1x | 5.8x |
| Sun, 07 Jul 2024 | zł2.4b | zł413.5m | -zł32,092,283.00 | 19.1x | -75.9x | 5.9x |
| Tue, 04 Jun 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.4x | -78.3x | 6.1x |
| Thu, 02 May 2024 | zł2.5b | zł421.0m | -zł26,364,957.00 | 18.3x | -94.6x | 5.9x |
| Sat, 30 Mar 2024 | zł2.6b | zł478.9m | -zł71,866,957.00 | 50.2x | -35.8x | 5.4x |
| Mon, 26 Feb 2024 | zł2.5b | zł495.9m | -zł52,637,957.00 | 43.8x | -47.4x | 5x |
| Wed, 24 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 45.2x | -49.3x | 5x |
| Fri, 22 Dec 2023 | zł2.6b | zł495.2m | -zł50,454,191.00 | 45.6x | -51x | 5.2x |
| Sun, 19 Nov 2023 | zł2.5b | zł509.3m | -zł33,328,342.00 | 31.6x | -74.8x | 4.9x |
| Tue, 17 Oct 2023 | zł2.9b | zł512.0m | -zł37,354,934.00 | 33.5x | -76.5x | 5.6x |
| Thu, 14 Sep 2023 | zł2.7b | zł507.5m | -zł51,266,934.00 | 41.3x | -53.2x | 5.4x |
| Sat, 12 Aug 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 47.8x | -46.9x | 5.6x |
Price to Earnings Ratio
-46.9x
Current Industry PE
- Investors are pessimistic on the Polish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.2x is higher than the industry's current PS ratio of 2.2x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 4.4% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 4.33% | |
| Healthcare | 1.48% | |
| Life Sciences | 4.36% | |
| Clinical Research and Equipment | 4.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł28.25 | 8.7% +zł41.3m | -18.6% | PS1.4x | |
| RVU Ryvu Therapeutics | zł15.10 | 0.7% +zł2.3m | -51.1% | PS4x |